EP
MD icon

Essential Partners’s Pediatrix Medical MD Stock Holding History

Essential Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14K Sell
124
-788
-86% -$17.9K ﹤0.01% 1770
2026
Q1 		$19.5K Sell
912
-1
-0.1% -$21 0.01% 940
2025
Q4 		$19.5K Buy
913
+161
+21% +$3.3K 0.01% 917
2025
Q3 		$12.6K Buy
752
+623
+483% +$9.34K ﹤0.01% 1072
2025
Q2 		$1.85K Buy
+129
New +$1.77K ﹤0.01% 1339

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Essential Partners's MD Position: Q2 2026 in Review

Essential Partners reduced its Pediatrix Medical (MD) stake by 86% in Q2 2026, selling an estimated $17.9K and leaving 124 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

Essential Partners first reported a position in MD in Q2 2025 and has held it in 5 quarters since. The position peaked at $19.5K in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Essential Partners held 124 shares of Pediatrix Medical worth $3.14K as of Q2 2026.
  • Essential Partners sold 788 Pediatrix Medical shares in Q2 2026, an estimated $17.9K.
  • Pediatrix Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1770 holding.
  • Essential Partners first reported a position in Pediatrix Medical in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Pediatrix Medical position peaked at $19.5K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.